Phaseline

Companies › LG Chem

LG Chem: clinical trials, targets and expected readouts

4 active drug programs in 16 registered trials: 8 Phase 2, 4 Phase 4, 3 Phase 3, 1 Phase 1; Genitourinary, Oncology, Gastroenterology, Metabolic and endocrine; next expected readout Nov 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Leuprolide
Gonadotropin-releasing hormone receptor agonist
GNRHRPhase 4Central Precocious Puberty; Prostate Cancer; Androgen Deprivation Therapy; Advanced Salivary Gland Carcinoma …Aug 2029
Fang Le Shu (Follitrope)
Recombinant follicle-stimulating hormone (rFSH)
FSHRPhase 4Female Infertility–
LBVD
Fully liquid hexavalent vaccine containing diphtheria toxoid, tetanus toxoid, whole cell p
–Phase 2DiphtheriaFeb 2028
LB-LR1109–Phase 1Non-small Cell Lung Cancer(NSCLC)Nov 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06921395Fang Le Shu (Follitrope)Phase 4Female InfertilityGenitourinaryDec 2025
NCT06627530LeuprolidePhase 4Prostate CancerOncologyDec 2026
NCT05924256LeuprolidePhase 2Advanced Salivary Gland CarcinomaOncologyDec 2026
NCT05478083LeuprolidePhase 2Polycystic Liver DiseaseGastroenterologyJun 2027
NCT04302454LeuprolidePhase 3Prostate CancerOncologyOct 2027
NCT06332755LB-LR1109Phase 1Non-small Cell Lung Cancer(NSCLC)OncologyNov 2027
NCT01492972LeuprolidePhase 3Prostate CancerOncologyDec 2027
NCT07158021LeuprolidePhase 2Anatomic Stage I Breast Cancer AJCC v8OncologyJan 2028
NCT06947499LBVDPhase 2DiphtheriaInfectious diseaseFeb 2028
NCT06145308LeuprolidePhase 2Salivary Gland CarcinomaOncologyJul 2028
NCT07848828LeuprolidePhase 4Androgen Deprivation TherapyGenitourinaryJul 2028
NCT02221999LeuprolidePhase 2Tubular Breast CancerOncologyJan 2029
NCT07710430LeuprolidePhase 4Central Precocious PubertyMetabolic and endocrineAug 2029
NCT07455903LeuprolidePhase 2Prostate CancerOncologyFeb 2030
NCT06397703LeuprolidePhase 2Prostate CancerOncologyApr 2030
NCT05781217LeuprolidePhase 3Prostate CancerOncologyDec 2032

Targets

GNRHR (1) FSHR (1)

Companies with the same targets

Qilu Pharmaceutical Clinique Ovo JW Pharmaceutical Amgen AbbVie Pfizer TerSera Therapeutics Zhuhai Huahaikang Pharmaceutical Technology Kissei Pharmaceutical Changchun GeneScience Pharmaceutical

Companies built like this

Calico Life Sciences Everest Medicines (China) Sumitomo Pharma Switzerland Dong-A ST Kissei Pharmaceutical

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.